SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Riccardo Zambelloni, Rudi Marquez, Andrew J. Roe, Development of Antivirulence Compounds: A Biochemical Review, Chemical Biology & Drug Design, 2015, 85, 1
  2. 2
    Andrew C. McShan, Roberto N. De Guzman, The Bacterial Type III Secretion System as a Target for Developing New Antibiotics, Chemical Biology & Drug Design, 2015, 85, 1
  3. 3
    Alexandra Dostal, Jeannine Baumgartner, Nathalie Riesen, Christophe Chassard, Cornelius M. Smuts, Michael B. Zimmermann, Christophe Lacroix, Effects of iron supplementation on dominant bacterial groups in the gut, faecal SCFA and gut inflammation: a randomised, placebo-controlled intervention trial in South African children, British Journal of Nutrition, 2014, 112, 04, 547

    CrossRef

  4. 4
    Katherine S. H. Beckham, Andrew J. Roe, From screen to target: insights and approaches for the development of anti-virulence compounds, Frontiers in Cellular and Infection Microbiology, 2014, 4,

    CrossRef

  5. 5
    Shoghik Hakobyan, Jean-François Boily, Madeleine Ramstedt, Proton and gallium(III) binding properties of a biologically active salicylidene acylhydrazide, Journal of Inorganic Biochemistry, 2014, 138, 9

    CrossRef

  6. 6
    Fan Yang, Schuyler S. Korban, P. Lawrence Pusey, Michael Elofsson, George W. Sundin, Youfu Zhao, Small-molecule inhibitors suppress the expression of both type III secretion and amylovoran biosynthesis genes in Erwinia amylovora, Molecular Plant Pathology, 2014, 15, 1
  7. 7
    Natalie C Marshall, B Brett Finlay, Targeting the type III secretion system to treat bacterial infections, Expert Opinion on Therapeutic Targets, 2014, 18, 2, 137

    CrossRef

  8. 8
    Lun K. Tsou, Paul D. Dossa, Howard C. Hang, Small molecules aimed at type III secretion systems to inhibit bacterial virulence, MedChemComm, 2013, 4, 1, 68

    CrossRef

  9. 9
    Speranta Puiac, XiaoHui Sem, Aurel Negrea, Mikael Rhen, Small-molecular virulence inhibitors show divergent and immunomodulatory effects in infection models of Salmonella enterica serovar Typhimurium, International Journal of Antimicrobial Agents, 2011, 38, 5, 409

    CrossRef

  10. 10
    Magali Hébrard, Carsten Kröger, Sathesh K Sivasankaran, Kristian Händler, Jay CD Hinton, The challenge of relating gene expression to the virulence of Salmonella enterica serovar Typhimurium, Current Opinion in Biotechnology, 2011, 22, 2, 200

    CrossRef